Literature DB >> 22715107

Identification of novel target proteins in sebaceous gland carcinoma.

Boban M Erovic1, Ayman Al Habeeb, Luke Harris, David P Goldstein, Dae Kim, Danny Ghazarian, Jonathan C Irish.   

Abstract

BACKGROUND: The aim of this study was to identify new target proteins in sebaceous gland carcinoma.
METHODS: A tissue microarray containing 115 core biopsies was constructed and stained for proteins involved in carcinogenesis, angiogenesis, inflammation, and cell-to-cell contact. Two investigators independently determined protein expression of all antibodies.
RESULTS: Vascular endothelial growth factor receptor 2 (VEGFR-2), platelet-derived growth factor receptor alpha and beta (PDGFR-α/-β), epidermal growth factor receptor (EGFR), cyclooxygenase 1 and 2 (Cox-1/-2), myeloid cell leukemia sequence 1 (Mcl-1), matrix metalloproteinase 1 (MMP-1), CD9, Bmi-1, 14-3-3σ, glutathione S-transferase pi (Gstπ), and members of the sonic hedgehog (SHH), AKT, and WNT pathways were significantly overexpressed in sebaceous gland carcinomas.
CONCLUSIONS: We have demonstrated for the first time that proteins related to angiogenesis, inflammation, and cell proliferation are overexpressed in sebaceous gland carcinomas. These proteins may hold promise as novel therapeutic targets for the treatment of sebaceous gland carcinoma.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22715107     DOI: 10.1002/hed.23021

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  5 in total

1.  CDKN2A, CDK1, and CCNE1 overexpression in sebaceous gland carcinoma of eyelid.

Authors:  Tatsuya Yunoki; Tetsushi Hirano; Yoshiaki Tabuchi; Yukihiro Furusawa; Misako Torigoe; Takahiko Nakajima; Johji Imura; Atsushi Hayashi
Journal:  Int Ophthalmol       Date:  2019-09-30       Impact factor: 2.031

2.  Increased gene copy number of HER2 and concordant protein overexpression found in a subset of eyelid sebaceous gland carcinoma indicate HER2 as a potential therapeutic target.

Authors:  Min Joung Lee; Namju Kim; Ho-Kyung Choung; Ji-Young Choe; Sang In Khwarg; Ji Eun Kim
Journal:  J Cancer Res Clin Oncol       Date:  2015-07-04       Impact factor: 4.553

Review 3.  Proteolytic activity in the meibomian gland: Implications to health and disease.

Authors:  Pablo Argüeso
Journal:  Exp Eye Res       Date:  2017-03-08       Impact factor: 3.467

Review 4.  Birt-Hogg-Dubé syndrome and the skin.

Authors:  Marigje Vernooij; Tijs Claessens; Monique Luijten; Maurice A M van Steensel; Barry J Coull
Journal:  Fam Cancer       Date:  2013-09       Impact factor: 2.375

5.  Bioinformatics analysis of the microRNA-mRNA network in sebaceous gland carcinoma of the eyelid.

Authors:  Tetsushi Hirano; Tatsuya Yunoki; Yukihiro Furusawa; Yoshiaki Tabuchi; Atsushi Hayashi
Journal:  Mol Med Rep       Date:  2020-11-12       Impact factor: 2.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.